Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

1Q7G

Homoserine Dehydrogenase in complex with suicide inhibitor complex NAD-5-hydroxy-4-Oxonorvaline

Summary for 1Q7G
Entry DOI10.2210/pdb1q7g/pdb
DescriptorHomoserine dehydrogenase, SODIUM ION, NICOTINAMIDE-ADENINE-DINUCLEOTIDE-5-HYDROXY-4-OXONORVALINE, ... (4 entities in total)
Functional Keywordsoxidoreductase
Biological sourceSaccharomyces cerevisiae (baker's yeast)
Total number of polymer chains2
Total formula weight77945.45
Authors
Jacques, S.L.,Mirza, I.A.,Ejim, L.,Koteva, K.,Hughes, D.W.,Green, K.,Kinach, R.,Honek, J.F.,Lai, H.K.,Berghuis, A.M.,Wright, G.D. (deposition date: 2003-08-18, release date: 2003-10-21, Last modification date: 2023-08-16)
Primary citationJacques, S.L.,Mirza, I.A.,Ejim, L.,Koteva, K.,Hughes, D.W.,Green, K.,Kinach, R.,Honek, J.F.,Lai, H.K.,Berghuis, A.M.,Wright, G.D.
Enzyme assisted suicide: Molecular basis for the antifungal activity of 5-hydroxy-4-oxonorvaline by potent inhibition of homoserine dehydrogenase
Chem.Biol., 10:989-995, 2003
Cited by
PubMed Abstract: The structure of the antifungal drug 5-hydroxy-4-oxonorvaline (HON) in complex with its target homoserine dehydrogenase (HSD) has been determined by X-ray diffraction to 2.6 A resolution. HON shows potent in vitro and in vivo activity against various fungal pathogens despite its weak (2 mM) affinity for HSD in the steady state. The structure together with structure-activity relationship studies, mass spectrometry experiments, and spectroscopic data reveals that the molecular mechanism of antifungal action conferred by HON involves enzyme-dependent formation of a covalent adduct between C4 of the nicotinamide ring of NAD(+) and C5 of HON. Furthermore, novel interactions are involved in stabilizing the (HON*NAD)-adduct, which are not observed in the enzyme's ternary complex structure. These findings clarify the apparent paradox of the potent antifungal actions of HON given its weak steady-state inhibition characteristics.
PubMed: 14583265
DOI: 10.1016/j.chembiol.2003.09.015
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.6 Å)
Structure validation

237735

数据于2025-06-18公开中

PDB statisticsPDBj update infoContact PDBjnumon